The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Andre C. Kalil

Department of Internal Medicine

University of Nebraska Medical Center

Omaha

NE 68198-5400

USA

[email]@unmc.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198-5400, USA. 2005 - 2012
  • Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, USA. 2006

References

  1. Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression. Kalil, A.C., LaRosa, S.P. Lancet. Infect. Dis (2012) [Pubmed]
  2. IMPACT trial results should not change current standard of care of 100 days for cytomegalovirus prophylaxis. Kalil, A.C., Sun, J., Florescu, D.F. Am. J. Transplant. (2011) [Pubmed]
  3. Effectiveness of valganciclovir 900 mg versus 450 mg for cytomegalovirus prophylaxis in transplantation: direct and indirect treatment comparison meta-analysis. Kalil, A.C., Mindru, C., Florescu, D.F. Clin. Infect. Dis. (2011) [Pubmed]
  4. Low-dose steroids for septic shock and severe sepsis: the use of Bayesian statistics to resolve clinical trial controversies. Kalil, A.C., Sun, J. Intensive. Care. Med (2011) [Pubmed]
  5. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis. Kalil, A.C., Murthy, M.H., Hermsen, E.D., Neto, F.K., Sun, J., Rupp, M.E. Crit. Care Med. (2010) [Pubmed]
  6. Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy. Kalil, A.C., Freifeld, A.G., Lyden, E.R., Stoner, J.A. PLoS. ONE (2009) [Pubmed]
  7. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Kalil, A.C., Florescu, D.F. Crit. Care Med. (2009) [Pubmed]
  8. How many patients with severe sepsis are needed to confirm the efficacy of drotrecogin alfa activated? A Bayesian design. Kalil, A.C., Sun, J. Intensive. Care. Med (2008) [Pubmed]
  9. Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysis. Kalil, A.C., Sun, J. PLoS. ONE (2008) [Pubmed]
  10. Sepsis and solid organ transplantation. Kalil, A.C., Dakroub, H., Freifeld, A.G. Curr. Drug. Targets (2007) [Pubmed]
  11. Preclinical trial of L-arginine monotherapy alone or with N-acetylcysteine in septic shock. Kalil, A.C., Sevransky, J.E., Myers, D.E., Esposito, C., Vandivier, R.W., Eichacker, P., Susla, G.M., Solomon, S.B., Csako, G., Costello, R., Sittler, K.J., Banks, S., Natanson, C., Danner, R.L. Crit. Care Med. (2006) [Pubmed]
  12. L-Arginine supplementation in sepsis: beneficial or harmful?. Kalil, A.C., Danner, R.L. Curr. Opin. Crit. Care (2006) [Pubmed]
  13. Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases. Kalil, A.C., Devetten, M.P., Singh, S., Lesiak, B., Poage, D.P., Bargenquast, K., Fayad, P., Freifeld, A.G. Clin. Infect. Dis. (2005) [Pubmed]
  14. Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Kalil, A.C., Levitsky, J., Lyden, E., Stoner, J., Freifeld, A.G. Ann. Intern. Med. (2005) [Pubmed]
 
WikiGenes - Universities